Cette page a été traduite automatiquement et l'exactitude de la traduction n'est pas garantie. Veuillez vous référer au version anglaise pour un texte source.

Assessing Feasibility of Evaluating Provider Experience With a Remote Therapeutic Monitoring Platform

25 août 2026 mis à jour par: Adly A Adam

Assessing Feasibility of Evaluating Provider Experience With a Remote Therapeutic Monitoring Platform: A Cross-Sectional Survey of Clinician Workload, Therapeutic Alliance, and Satisfaction

: Remote therapeutic monitoring (RTM) platforms were increasingly deployed in Outpatient Rehabilitation to support continuous, between-visit communication, adherence to home exercise programs, and earlier identification of clinical setbacks. While patient-facing outcomes have received growing attention, evidence describing the clinician experience of RTM; including its effects on therapeutic alliance, perceived cognitive workload, and capacity for proactive patient management remains limited. Understanding how providers perceive and integrate RTM technology into their workflows is essential to optimizing implementation, sustaining adoption, and translating digital health investment into measurable clinical value. This cross-sectional survey study tested the feasibility of evaluating the provider's experience using a digital RTM platform across three pre-specified domains: 1) therapeutic alliance, 2) work satisfaction, plus cognitive loading, and 3) proactive patient management. A secondary objective examined whether years of clinical experience or self-reported comfort with new technology were associated with provider experience or perceived workload.A cross-sectional, anonymous survey was administered to licensed physical therapists at the Outpatient Clinics, Shebin El-Kom, Menofyia governate, Egypt between 1st March, and 31th July, 2026 with a response rate of 43.4% (43/99) for the completed surveys. Eligible clinicians used the SaRA Health RTM platform for at least the previous six months prior to initiation of current study. The survey instrument combined an internally developed 8-item Likert-scale survey (0-5) targeting therapeutic alliance, proactive management, and satisfaction (Cronbach's α = 0.89) with a modified NASA Task Load Index (NASA-TLX; Cronbach's α = 0.86) measured the perceived workload across six domains (0-10). Cronbach's α coefficient demonstrates internal consistency, unless not construct validity or test-retest reliability. Statistical analyses included Spearman rank-order correlations and Mann-Whitney-U tests. For Mann-Whitney comparisons, results were reported as: U, p-value, group sample sizes (N1, N2), and rank-biserial r-effect size. For multiple comparisons across NASA-TLX subscales (k = 6), a Bonferroni-corrected threshold of α = .0083 was applied. Spearman correlations were reported with ρ and 95% confidence intervals.In this cross-sectional survey feasibility study, it was observed that clinician experience with the SaRA Health RTM platform was characterized by enhanced therapeutic alliance when early warning detection performed well, reduced cognitive load was observed when frustration was low, and meaningful facilitation of proactive patient management was observed among engaged users. Frustration emerged as the most actionable lever for design and implementation improvement, and self-reported digital comfort rather than years of clinical experience was the strongest clinician-level correlate of cognitive burden. These findings suggest that targeted onboarding, mentorship, and friction-reducing platform refinements may improve RTM adoption and amplify downstream benefits to patient care. Larger, multi-site, longitudinal studies are warranted to validate these signals.

Aperçu de l'étude

Description détaillée

Remote Therapeutic Monitoring (RTM) has emerged as an increasingly important component of contemporary rehabilitation delivery, particularly within outpatient musculoskeletal care. The introduction of RTM-specific CPT codes beginning in 2022 to include patient-reported subjective data, has created reimbursement pathways that support integration of RTM into physical therapy practice by enabling clinicians to monitor patient progress, adherence, symptoms, and treatment response between in-person visits. Digital-health technologies may strengthen this alliance by providing easy access to communication with clinicians in between visits, enhancing continuity, and supporting personalized feedback between visits. Recent evidence suggests that digital-health interventions can positively influence patient-provider relationships when technologies are perceived as supportive rather than intrusive or burdensome. A feasibility, cross-sectional, quantitative survey was conducted at the Outpatient Clinics, Shebin El-Kom, Menofyia governate, Egypt between 1st March, and 31th July, 2026. The Outpatient Clinics provide care to adult patients with musculoskeletal, and neuromuscular conditions. Participating clinicians were defined as licensed physical therapists (PTs). All participants were recruited voluntarily and checked an informed consent box through an emailed request. Across three pre-specified objectives for this cross-sectional, quantitative survey study, the SaRA Health RTM platform demonstrated observational signals consistent with improved therapeutic alliance when early warning detection performed well, reduced cognitive load when frustration with the platform was minimized, and meaningful facilitation of proactive patient management among clinicians who experienced the RTM process as positive. Frustration emerged as the single most actionable target for improvement, and lower self-reported digital comfort was the clinician characteristic most associated with elevated cognitive load and reduced performance on the modified NASA task index. Together these findings suggest clinician experience design, education, and training as important determinants of whether this specific RTM platform translates into the proactive, alliance-strengthening care it is intended to enable.

Type d'étude

Observationnel

Inscription (Réel)

45

Contacts et emplacements

Cette section fournit les coordonnées de ceux qui mènent l'étude et des informations sur le lieu où cette étude est menée.

Lieux d'étude

    • Menofyia
      • Shibīn al Kawm, Menofyia, Egypte, 11432
        • Shebin ElKom Teaching Hospital

Critères de participation

Les chercheurs recherchent des personnes qui correspondent à une certaine description, appelée critères d'éligibilité. Certains exemples de ces critères sont l'état de santé général d'une personne ou des traitements antérieurs.

Critère d'éligibilité

Âges éligibles pour étudier

  • Adulte

Accepte les volontaires sains

Non

Méthode d'échantillonnage

Échantillon non probabiliste

Population étudiée

Clinicians used the SaRA Health RTM platform for at least the previous six months prior to initiation of current study. Licensed physical therapists providing Outpatient care to adult patients at the Outpatient Clinics, Shebin El-Kom, Menofyia governate, Egypt, who had used the SaRA Health RTM platform at least six months prior and during the study period. Exclusion: clinicians without direct RTM-platform exposure and respondents with incomplete surveys on key outcome items.

La description

Inclusion Criteria:

  • Licensed physical therapists providing Outpatient care to adult patients at the Outpatient Clinics, Shebin El-Kom, Menofyia governate, Egypt, who had used the SaRA Health RTM platform at least six months prior and during the study period.
  • A range of physical therapy experience levels and professions.
  • Clinicians used the SaRA Health RTM platform for at least the previous six months prior to initiation of current study.

Exclusion Criteria:

  • Clinicians without direct RTM-platform exposure and respondents with incomplete surveys on key outcome items

Plan d'étude

Cette section fournit des détails sur le plan d'étude, y compris la façon dont l'étude est conçue et ce que l'étude mesure.

Comment l'étude est-elle conçue ?

Détails de conception

Cohortes et interventions

Groupe / Cohorte
Intervention / Traitement
Experimental Group
45 Licensed physical therapists providing Outpatient care to adult patients at the Outpatient Clinics, Shebin El-Kom, Menofyia governate, Egypt, who had used the SaRA Health RTM platform at least six months prior and during the study period. Exclusion: clinicians without direct RTM-platform exposure and respondents with incomplete surveys on key outcome items. Participants represent a range of experience levels and professions. Respondents were asked about their comfort with technology, the number of patient-care hours they delivered weekly, and the proportion of their caseload enrolled on the SaRA Health RTM platform
The survey was administered anonymously and consisted of two principal instruments: 1) an internally developed 8-item Likert-scale survey examining clinician experiences with the SaRA Health RTM platform and its perceived contribution to patient care plans, and 2) a modified, non-validated NASA Task Load Index (NASA-TLX) that captured perceived cognitive and physical workload, time pressure, performance (defined as the ability to complete work), effort, and frustration associated with platform use. The validated tool is generally used without modification using a 0-100 scale. We modified the scale to 0-10 with '0' representing the lowest end of each domain. The internally developed survey, designed by the SaRA Health research team, comprised 8 items rated on a Likert scale from 1 (strongly disagree) to 5 (strongly agree). Items targeted clinician perceptions of therapeutic alliance, proactive patient management, and work satisfaction associated with use of the RTM system.

Que mesure l'étude ?

Principaux critères de jugement

Mesure des résultats
Description de la mesure
Délai
A modified, non-validated NASA Task Load Index (NASA-TLX)
Délai: 1. At base-line of the study.
A modified, non-validated NASA Task Load Index (NASA-TLX) measures perceived workload of human-machine systems across six domains and has been used extensively in the healthcare field to exam workload for providers using digital health technologies. The validated tool is generally used without modification using a 0-100 scale. We modified the scale to 0-10 with '0' representing the lowest end of each domain. For example, a score of 0 on the mental demand item indicates no additional mental load attributable to the system, whereas a score of '10' indicates extremely high additional mental load. The original instrument served as a template; item wording was lightly modified to reflect the RTM use case more specifically.
1. At base-line of the study.
An internally developed 8-item Likert-scale survey
Délai: 1. At base-line of the study.
An internally developed 8-item Likert-scale survey designed by the SaRA Health research team, comprised 8 items rated on a Likert scale from 1 (strongly disagree) to 5 (strongly agree). Items targeted clinician perceptions of therapeutic alliance, proactive patient management, and work satisfaction associated with use of the RTM system.
1. At base-line of the study.

Collaborateurs et enquêteurs

C'est ici que vous trouverez les personnes et les organisations impliquées dans cette étude.

Parrainer

Dates d'enregistrement des études

Ces dates suivent la progression des dossiers d'étude et des soumissions de résultats sommaires à ClinicalTrials.gov. Les dossiers d'étude et les résultats rapportés sont examinés par la Bibliothèque nationale de médecine (NLM) pour s'assurer qu'ils répondent à des normes de contrôle de qualité spécifiques avant d'être publiés sur le site Web public.

Dates principales de l'étude

Début de l'étude (Réel)

1 mars 2026

Achèvement primaire (Réel)

1 juin 2026

Achèvement de l'étude (Réel)

30 juillet 2026

Dates d'inscription aux études

Première soumission

23 août 2026

Première soumission répondant aux critères de contrôle qualité

25 août 2026

Première publication (Réel)

27 août 2026

Mises à jour des dossiers d'étude

Dernière mise à jour publiée (Réel)

27 août 2026

Dernière mise à jour soumise répondant aux critères de contrôle qualité

25 août 2026

Dernière vérification

1 août 2026

Plus d'information

Termes liés à cette étude

Informations sur les médicaments et les dispositifs, documents d'étude

Étudie un produit pharmaceutique réglementé par la FDA américaine

Non

Étudie un produit d'appareil réglementé par la FDA américaine

Non

Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .

S'abonner